Increased fetal loss in women with heritable thrombophilia
- 5 October 1996
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 348 (9032), 913-916
- https://doi.org/10.1016/s0140-6736(96)04125-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- World distribution of factor V LeidenThe Lancet, 1995
- Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient familiesBlood, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Lupus Anticoagulants, Anticardiolipin Antibodies, and Fetal LossObstetrical & Gynecological Survey, 1992
- Lupus Anticoagulants, Anticardiolipin Antibodies, and Fetal Loss: A Case–Control StudyThe New England Journal of Medicine, 1991
- Recurrent miscarriage I: definition and epidemiologyThe Lancet, 1990
- Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodiesBritish Journal of Haematology, 1990